Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Other Operating Expenses: 2010-2021

Historic Other Operating Expenses for Neurocrine Biosciences (NBIX) over the last 10 years, with Sep 2021 value amounting to $4.2 million.

  • Neurocrine Biosciences' Other Operating Expenses fell 96.53% to $4.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $191.3 million, marking a year-over-year decrease of 28.01%. This contributed to the annual value of $882.9 million for FY2020, which is 144.07% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Other Operating Expenses of $4.2 million as of Q3 2021, which was down 48.15% from $8.1 million recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Other Operating Expenses high stood at $176.1 million for Q4 2020, and its period low was $61,000 during Q2 2017.
  • Its 3-year average for Other Operating Expenses is $52.7 million, with a median of $8.1 million in 2021.
  • As far as peak fluctuations go, Neurocrine Biosciences' Other Operating Expenses skyrocketed by 11,926.11% in 2019, and later slumped by 98.16% in 2020.
  • Neurocrine Biosciences' Other Operating Expenses (Quarterly) stood at $760,000 in 2017, then surged by 101.84% to $1.5 million in 2018, then spiked by 6,030.25% to $94.0 million in 2019, then soared by 87.26% to $176.1 million in 2020, then plummeted by 96.53% to $4.2 million in 2021.
  • Its last three reported values are $4.2 million in Q3 2021, $8.1 million for Q2 2021, and $2.9 million during Q1 2021.